Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Healthcare Medical Devices
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes

PR Newswire November 8, 2023

Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology

Accesswire November 2, 2023

Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV

PR Newswire November 2, 2023

Abbott and Damar Hamlin Team Up To Build Heart Health Community With New Heartmates Program

Accesswire November 1, 2023

Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology

PR Newswire November 1, 2023

Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program

PR Newswire October 31, 2023

Tackling Student Loans and Saving - Together

Accesswire October 30, 2023

Ninety-One Percent of Young Adults With Student Loans Say Financial Stress Is Impacting Their Wellness

Accesswire October 26, 2023

Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem

PR Newswire October 26, 2023

Late-Breaking Data Show Esprit(TM) BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care

PR Newswire October 25, 2023

Can Health Tech Be the Most Helpful Technology of All?

Accesswire October 25, 2023

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

PR Newswire October 24, 2023

Sharing the Access Code to Help Open Up Diabetes Care

Accesswire October 24, 2023

Abbott Recognized on Fortune Change the World List

Accesswire October 19, 2023

Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range

PR Newswire October 18, 2023

Abbott Hosts Conference Call for Third-Quarter Earnings

PR Newswire September 27, 2023

Abbott Shares Progress on Sustainability Performance, Including Company's Priority of Innovating for Greater Health Access

Accesswire September 26, 2023

Abbott Completes Acquisition of Bigfoot Biomedical

PR Newswire September 22, 2023

Abbott Declares 399th Consecutive Quarterly Dividend

PR Newswire September 21, 2023

Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

PR Newswire September 20, 2023